
Ichnos Glenmark, AbbVie ink USD 2-bn licensing deal for commercialisation of investigational asset
Glenmark Pharmaceuticals Ltd on Thursday said it has signed a deal with AbbVie to commmercialise its underdevelopment drug aimed to treat cancer and autoimmune diseases in an up to USD 2 billion deal, one of the largest transactions in the pharma sector. …